Methods This retrospective, case-series describes the initial presentation and management
of MIS in four children and four adults seen at WRNMMC from March 2020 to September …

Abstract Purpose of Review Multisystem inflammatory disease in children (MIS-C) is a novel
post-infectious phenomenon following coronavirus disease-19 (COVID-19). Herein, we …

Abstract The coronavirus disease-2019 (COVID-19) has (as of Oct. 14, 2020) infected
approximately 38 million people worldwide. The most feared sequelae of COVID-19 in …

Abstract Background Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare
hyperinflammatory condition that occurs following SARS-CoV-2 infection. There is a paucity …

Multisystem inflammatory syndrome in children (MIS-C) is a relatively rare, but potentially life-
threatening, post-infectious phenomenon, with an incidence of 2 per 100,000 SARS-CoV-2 …

Background Previous findings from the Swissped RECOVERY trial showed that patients with
Pediatric Inflammatory Multisystem Syndrome–Temporally Associated with SARS-CoV-2 …

BACKGROUND SARS-CoV-2 infection can lead to multisystem inflammatory syndrome in
children (MIS-C). We investigated risk factors for severe disease and explored changes in …

MIS-C is a novel clinical syndrome in children and adolescents, was first encountered in the
spring of 2020 as a post COVID-19 multisystem inflammatory syndrome. The highest …

Background Understanding the epidemiology and clinical course of multisystem
inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus …

Importance Multisystem inflammatory syndrome in children (MIS-C) causes severe
inflammation of multiple organ systems after SARS-CoV-2 infection. During the pandemic …